Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.
| Journal | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer |
| Study Type | Observational Study |
| Population | Human participants |
Cancer survivors face complex symptom management decisions, and perceived stigma can create barriers to discussing cannabis therapeutics with their care teams. Understanding patient perspectives on cannabis stigma helps clinicians create more supportive environments for evidence-based symptom management discussions.
This mixed-methods study examined stigma perceptions among 23 cancer survivors in the Northeast U.S., including 10 cannabis users and 13 non-users. The sample demonstrated generally positive attitudes toward cannabis use for symptom management. Most participants reported feeling minimal stigma regarding cannabis use and did not feel judged by their healthcare providers. Both cannabis users and non-users expressed acceptance or neutrality toward other cancer survivors using cannabis for symptom relief.
“These findings align with what I observe clinically – cancer survivors tend to be pragmatic about symptom management tools, including cannabis, when conventional approaches fall short. The reported comfort with provider discussions suggests we’re making progress in normalizing these therapeutic conversations.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
Do cancer survivors experience stigma when using cannabis for symptom management?
According to this study of 23 cancer survivors, most participants did not report experiencing stigma related to cannabis use. The majority felt accepting or neutral about other cancer survivors using cannabis, regardless of their own usage status, and did not feel judged by their medical providers.
How do cancer survivors generally view cannabis as a treatment option?
The study found that cancer survivors generally held positive attitudes toward cannabis use. Participants indicated feeling empowered to pursue whatever treatments were necessary to improve their wellbeing, suggesting an open-minded approach to cannabis as a therapeutic option.
Are healthcare providers supportive of cannabis use among cancer survivors?
Based on patient perspectives in this study, most cancer survivors did not feel judged by their medical providers regarding cannabis use. This suggests that healthcare providers may be more accepting of cannabis use for symptom management in cancer care than previously assumed.
What factors influence cancer survivors’ decisions about using cannabis?
The study indicates that cancer survivors are primarily motivated by symptom management needs and feel empowered to make treatment decisions based on what helps them feel better. The relatively low stigma levels and positive attitudes suggest that social barriers may be less influential than clinical considerations.
Should oncologists discuss cannabis use with their cancer patients?
Given that cancer survivors in this study felt largely non-judged by providers and held positive attitudes toward cannabis, oncologists should consider proactively discussing cannabis as part of comprehensive symptom management. Open communication can help ensure safe, informed use and integration with other treatments.
